Drug-induced liver injury: morbidity, mortality, and Hy's law.

作者信息

Regev Arie, Björnsson Einar S

机构信息

Global Patient Safety, Eli-Lilly and Company and, Division of Gastroenterology and Hepatology, Indiana University School of Medicine, Indianapolis, Indiana.

Section of Gastroenterology and Hepatology, National University Hospital, Reykjavik, Iceland.

出版信息

Gastroenterology. 2014 Jul;147(1):20-4. doi: 10.1053/j.gastro.2014.05.027. Epub 2014 May 29.

DOI:10.1053/j.gastro.2014.05.027

PMID:24880009

Abstract

摘要

相似文献

[1]

Drug-induced liver injury: morbidity, mortality, and Hy's law.

Gastroenterology. 2014-7

[2]

Use of Hy's Law, R criteria, and nR criteria to predict acute liver failure or transplantation in patients with drug-induced liver injury.

Gastroenterology. 2015-2

[3]

Use of Hy's law and a new composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

Gastroenterology. 2014-4-1

[4]

Improved prediction of the need for liver transplantation in patients with drug-induced liver injury?

Gastroenterology. 2014-12

[5]

Reply: To PMID 24704526.

Gastroenterology. 2015-2

[6]

Reply: To PMID 24704526.

Gastroenterology. 2014-12

[7]

How will I know whether "an apple is ripe or rotten"? A new proposed composite algorithm to predict acute liver failure in patients with drug-induced liver injury.

Turk J Gastroenterol. 2014-6

[8]

Incidence of liver injury among cancer patients receiving chemotherapy in an integrated health system.

Pharmacoepidemiol Drug Saf. 2015-4

[9]

Risk of Acute Liver Failure in Patients With Drug-Induced Liver Injury: Evaluation of Hy's Law and a New Prognostic Model.

Clin Gastroenterol Hepatol. 2015-12

[10]

Anti-tuberculosis drug-induced liver injury in Shanghai: validation of Hy's Law.

Drug Saf. 2014-1

引用本文的文献

[1]

Natural History of Idiosyncratic Drug-Induced Liver Injury and Prognostic Models.

Liver Int. 2025-6

[2]

Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids.

Ther Clin Risk Manag. 2025-3-19

[3]

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2- breast cancer.

NPJ Breast Cancer. 2025-1-26

[4]

Clinical guidance for cannabidiol-associated hepatotoxicity: A narrative review.

J Gastroenterol Hepatol. 2024-12

[5]

Integrated Safety and Efficacy Analyses of Phase 3 Trials of a Microbiome Therapeutic for Recurrent CDI.

Infect Dis Ther. 2024-10

[6]

Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestat.

BMC Genomics. 2023-9-1

[7]

Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-expansion stage of a multicentre, open-label, phase I trial.

Br J Cancer. 2023-9

[8]

Hyperbilirubinemia in hospitalized patients: Etiology and outcomes.

J Investig Med. 2023-10

[9]

Drug-Induced Liver Injury with Commonly Used Antibiotics in the All of Us Research Program.

Clin Pharmacol Ther. 2023-8

[10]

Severe tyrosine-kinase inhibitor induced liver injury in metastatic renal cell carcinoma patients: two case reports assessed for causality using the updated RUCAM and review of the literature.

BMC Gastroenterol. 2022-2-5

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Drug-induced liver injury: morbidity, mortality, and Hy's law.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献